The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
The second day of Arogya Manthan 2022 had panel discussions with eminent thought leaders from relevant public and private sector organizations
AB PMJAY has been successful in providing quality health services to the beneficiaries who come from weak financial backgrounds
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
The Department of Health and Family Welfare updated the preparedness for transition to licensing of Class-A and Class-B medical devices with effect from 1st October, 2022 under Medical Devices Rules 2017
The Bulk Drug Parks to be developed under the scheme will provide common infrastructure facilities at one place thereby creating a robust ecosystem for the bulk drug manufacturing in the country and also reducing manufacturing cost significantly
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
The total budget of Rs. 3119.46 crores has been allocated/ released as a central share to States/UTs since the inception of the scheme and they have reported an expenditure of Rs. 2290.20 crores.
The total financial outlay of the scheme is Rs.500 crore for a period of five years from 2021-22 to 2025-26.
Subscribe To Our Newsletter & Stay Updated
